You are here

Article info

Article menu
Asthma
Original article
Antagonism of chemokine receptor CCR8 is ineffective in a primate model of asthma
Free

Authors

  • Lin Wang Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Tracy J Jenkins Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Department of Medicinal Chemistry, Biogen Idec Pharmaceuticals, Inc, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Mingshi Dai Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA World Financial Group, Inc., Lexington, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Wei Yin Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Aveo Oncology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Jacqueline C Pulido Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Westwood, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Elise LaMantia-Martin Charles River Laboratories Preclinical Services, Wilmington, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Martin R Hodge Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Immunoscience, Pfizer, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Timothy Ocain Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Seaside Therapeutics, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Roland Kolbeck Department of Cellular Immunology and Pharmacology, Millennium Pharmaceuticals Inc. (Current: Millennium: The Takeda Oncology Company), Cambridge, Massachusetts, USA Department of Respiratory, Inflammation and Autoimmunity, MedImmune, LLC, Gaithersburg, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Roland Kolbeck, Department of Respiratory, Inflammation and Autoimmunity, MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA; kolbeckr{at}medimmune.com
View Full Text

Citation

Wang L, Jenkins TJ, Dai M, et al
Antagonism of chemokine receptor CCR8 is ineffective in a primate model of asthma
Thorax 2013;68:506-512.

Publication history

  • Received November 17, 2012
  • Revised January 29, 2013
  • Accepted February 1, 2013
  • First published March 1, 2013.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions